Monte Rosa Therapeutics
GLUE
#7806
Rank
C$0.34 B
Marketcap
$5.62
Share price
1.54%
Change (1 day)
-41.35%
Change (1 year)

EPS for Monte Rosa Therapeutics (GLUE)

EPS in 2023 (TTM): -$3.47

According to Monte Rosa Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.65. In 2022 the company made an earnings per share (EPS) of -$3.26 an increase over its 2021 EPS that were of -$6.90.

EPS history for Monte Rosa Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.476.5%
2022-$3.26-52.81%
2021-$6.90193.97%
2020-$2.35